Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1Dermatologic 1CNS 1Breast 1

Conditions

Leukemia 26Leukemia, Myeloid, Chronic-Phase 22Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16Lymphoma 9Leukemia, Lymphocytic, Chronic, B-Cell 8Lymphoma, Follicular 7Lymphoma, B-Cell, Marginal Zone 7Leukemia, Myeloid, Acute 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia, Myeloid, Accelerated Phase 6Burkitt Lymphoma 6Waldenstrom Macroglobulinemia 5Neoplasms, Plasma Cell 5Multiple Myeloma 5Lymphoma, Non-Hodgkin 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Mantle-Cell 4Hodgkin Disease 4Blast Crisis 4Primary Myelofibrosis 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Myeloproliferative Disorders 3Myelodysplastic Syndromes 3Leukemia, Hairy Cell 3Thrombocythemia, Essential 2Recurrence 2Precancerous Conditions 2Polycythemia Vera 2Mycosis Fungoides 2

Interventions

Flow Cytometry 3Methylprednisolone 2Immunologic Techniques 2Alemtuzumab 2sargramostim 1dexamethasone acetate 1dexamethasone 21-phosphate 1aldesleukin 1Tacrolimus 1Quality of Life 1Psychiatric Rehabilitation 1Prednisone 1Patient Reported Outcome Measures 1Moxifloxacin 1Molecular Diagnostic Techniques 1Microarray Analysis 1Interleukin-12 Subunit p35 1Interleukin-11 1Interferon-alpha 1Immunotherapy 1Immunoenzyme Techniques 1Granisetron 1Gene Expression Profiling 1Filgrastim 1ER 30346 1Drug Therapy 1Dexamethasone 1Data Collection 1Cyclophosphamide 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gestational Trophoblastic Disease × Interferon-alpha × Other hematologic neoplasm × Clear all
NCT00003408 2013-03-26

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer

National Cancer Institute (NCI)

Phase 2 Completed
40 enrolled
BreastCNSDermatologicGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Teratoma, Testicular, Testicular Germ Cell Tumor, Carcinoma, Ovarian Epithelial, Blast Crisis, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Kidney Neoplasms, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Myeloproliferative Disorders, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Recurrence, Sarcoma, Sezary Syndrome, Teratoma, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Gestational Trophoblastic Disease, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡